Customizable Cell Free DNA Precise Non Invasive Prenatal Testing NIPT Tube

Accurate Volume DHA Sterile And Safe Compatible With Equipment Customization

1. Product Description

Orsin Medical Technology’s Cell-Free DNA (cfDNA) Detection System revolutionizes disease diagnosis and monitoring through cutting-edge liquid biopsy technology. Our solution delivers highly sensitive, non-invasive, and real-time genomic analysis for early cancer screening, prenatal testing, transplant monitoring, and beyond.

Key Features & Advantages:

✔ Ultra-Sensitive Detection – Powered by NGS and proprietary bioinformatics, our platform detects trace cfDNA mutations with >99% accuracy, enabling early disease identification.
✔ Minimally Invasive – A simple blood draw replaces risky tissue biopsies, ensuring patient safety and comfort.
✔ Multi-Application Flexibility – Covers oncology (early cancer screening, MRD monitoring), NIPT (fetal aneuploidy detection), and transplant rejection tracking.
✔ Rapid & Scalable – High-throughput workflow delivers fast, reliable results, ideal for clinical and research use.
✔ AI-Enhanced Analysis – Our advanced algorithms improve mutation calling, reducing false positives/negatives.

2. Specification

Common Parameters by Tube Color (Example):

3 . Application

1. Hospital Routine Testing

• Scenario: Blood tests for routine diagnostics (CBC, biochemistry, coagulation) in outpatient/inpatient settings.

• Adaptability:

  • Accurate Volume Control (±5% tolerance) ensures consistent results and reduces retesting rates.

  • Multiple additives (EDTA, heparin, sodium citrate) tailored for diverse testing requirements.

  • Compatibility with automated analyzers (e.g., Roche, Siemens, Abbott) and seamless integration with hospital LIS/HIS systems.

2. Emergency & Critical Care

• Scenario: Rapid analysis of blood gases, electrolytes, and cardiac markers (e.g., troponin) in urgent care.

• Adaptability:

  • DHA (Dual Hemostasis Activator) Technology accelerates blood separation, reducing preprocessing time (<15 minutes).

  • Gray-top tubes (sodium fluoride/potassium oxalate) prevent glucose degradation for accurate emergency glucose testing.

3. Research & Laboratory Studies

• Scenario: Genomics (DNA/RNA extraction), proteomics, and drug metabolism research.

• Adaptability:

  • Sterile, non-pyrogenic design eliminates exogenous contamination, ideal for high-sensitivity assays (e.g., PCR, ELISA).

  • Customization options: additive-free tubes, low-adsorption tubes, or pre-filled specialty anticoagulants (e.g., CPDA-1).

4. Blood Banking & Transfusion Medicine

• Scenario: Blood component separation (plasma, RBCs, platelets), blood typing, and cross-matching.

• Adaptability:

  • Blue-top sodium citrate tubes (3.2% concentration) comply with international coagulation standards (CLSI H21-A5).

  • High-strength PET material ensures leak-proof integrity for safe cold-chain transport.

5. Pediatrics & Special Populations

• Scenario: Low-volume collection for neonates or patients with fragile veins.

• Adaptability:

  • Custom small-volume tubes (1-2ml) minimize blood draw, with color-coded caps (pink/yellow) for easy identification.

  • Smooth inner walls reduce hemolysis risk, compatible with fine needles (≤25G).

6. Epidemiology & Public Health

• Scenario: Large-scale screening (e.g., HIV, hepatitis, metabolic syndrome).

• Adaptability:

  • Batch-customized tubes with pre-printed barcodes/QR codes enable rapid sample tracking.

  • High-temperature-resistant glass tubes (optional) for processing infectious samples.

7. Telemedicine & POCT (Point-of-Care Testing)

• Scenario: Community clinics, home healthcare, and remote area testing.

• Adaptability:

  • Gel-separator tubes (orange cap) stabilize plasma/serum for up to 72 hours at 25°C.

  • Lightweight design compatible with portable centrifuges and POCT devices (e.g., i-STAT).

  •  

• • Why Choose Orsin’s cfDNA Solution?

  •  

  • Clinically Validated – Trusted by leading hospitals and labs.

  • Cost-Effective – Reduces unnecessary invasive procedures and long hospital stays.

  • Orsin Medical Technology empowers precision medicine with smarter, safer, and faster cfDNA diagnostics. Early detection. Better outcomes.

  • Future-Ready – Continuously optimized for emerging biomarkers (methylation, fragmentomics).